Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Hardy

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
The Journal of Biological Chemistry|December 18, 2020
A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.
Pageof 9